Altimmune股价上涨,因其季度亏损额低于预期

路透中文
Aug 12
BUZZ-Altimmune股价上涨,因其季度亏损额低于预期

8月12日 - ** 药物研发公司Altimmune(ALT.O)的股价在盘前交易中上涨4%,至3.13美元

** 该公司 (link) 公布第二季度每股亏损12美分,而分析师此前预计为每股亏损14美分

** 本月早些时候,该公司表示已针对一种名为“代谢功能障碍相关脂肪性肝炎”(一种肝病)的患者,启动了实验性药物pemvidutide的晚期临床研究,预计将于2029年公布为期52周的研究数据

** 截至6月30日,公司报告现金、现金等价物及投资总额为5.19亿美元

** 截至上一交易日收盘,该股年内累计跌幅达16.9%

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10